ANL (Adlai Nortye) Tariff Resilience Score: 5/10 (As of Jul. 05, 2026)


What is Adlai Nortye Tariff Resilience Score?

Adlai Nortye ANL -10.47% Tariff Resilience Score is 5 as of Jul. 05, 2026. The stock has 7 warning signs investors should review. Among 1,369 Biotechnology companies, Adlai Nortye ranks better than 62.38% on this metric.

Adlai Nortye has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Adlai Nortye has Adlai Nortye Ltd, a biotech firm, has moderate exposure due to its reliance on international clinical trials and imports. While it has some pricing power, its supply chain is vulnerable to disruptions. Historical tariffs have impacted costs, but alternative suppliers are available.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Adlai Nortye might have Average Resilient.

Adlai Nortye  (NAS:ANL) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Adlai Nortye Tariff Resilience Score Related Terms

ANL vs OMER, PRME, DNA: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Adlai Nortye's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adlai Nortye Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adlai Nortye's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Adlai Nortye's Tariff Resilience Score falls into.


What does a Tariff Resilience Score of 5 mean?
Adlai Nortye (ANL) has a Tariff Resilience Score of 5 as of Jul. 05, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Adlai Nortye ranks #515 out of 1369 companies in the Biotechnology industry, placing it in the top 37.6%.
Is Adlai Nortye's Tariff Resilience Score too high?
Adlai Nortye's current Tariff Resilience Score is 5. The Biotechnology industry median Tariff Resilience Score is 4.00. Adlai Nortye's value of 5 is 25% above this industry median. Based on the distribution chart, Adlai Nortye ranks #515 out of 1369 companies in the Biotechnology industry, which is above the industry midpoint.
How does Adlai Nortye's Tariff Resilience Score compare to OMER and PRME?
According to the Biotechnology industry distribution chart, Adlai Nortye ranks #515 out of 1369 companies for Tariff Resilience Score. This puts Adlai Nortye in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. Adlai Nortye's value of 5 is 25% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,369 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adlai Nortye's current Tariff Resilience Score of 5 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adlai Nortye's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adlai Nortye stock overvalued right now?
Adlai Nortye (ANL) has a current Tariff Resilience Score of 5. The current Tariff Resilience Score is 5 and 25% above the Biotechnology industry median of 4.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Adlai Nortye (ANL), the current Tariff Resilience Score is 5 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Adlai Nortye Business Description

Other Exchanges N2U0:Germany
Address 685 US Highway 1, New Jersey Biotechnology Development Center, 2nd Floor, North Brunswick, NJ, USA, 08902
Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.